|
Z12.0 Encounter for screening for malignant neoplasm of stomach |
|
Z12.10 Encounter for screening for malignant neoplasm of intestinal tract, unspecified |
|
Z12.11 Encounter for screening for malignant neoplasm of colon |
|
Z12.12 Encounter for screening for malignant neoplasm of rectum |
|
Z12.13 Encounter for screening for malignant neoplasm of small intestine |
|
Z12.2 Encounter for screening for malignant neoplasm of respiratory organs |
|
Z12.31 Encounter for screening mammogram for malignant neoplasm of breast |
|
Z12.39 Encounter for other screening for malignant neoplasm of breast |
|
Z12.4 Encounter for screening for malignant neoplasm of cervix |
|
Z12.5 Encounter for screening for malignant neoplasm of prostate |
|
Z12.6 Encounter for screening for malignant neoplasm of bladder |
|
Z12.71 Encounter for screening for malignant neoplasm of testis |
|
Z12.72 Encounter for screening for malignant neoplasm of vagina |
|
Z12.73 Encounter for screening for malignant neoplasm of ovary |
|
Z12.79 Encounter for screening for malignant neoplasm of other genitourinary organs |
|
Z12.81 Encounter for screening for malignant neoplasm of oral cavity |
|
Z12.82 Encounter for screening for malignant neoplasm of nervous system |
|
Z12.83 Encounter for screening for malignant neoplasm of skin |
|
Z12.89 Encounter for screening for malignant neoplasm of other sites |
|
Z12.9 Encounter for screening for malignant neoplasm, site unspecified |
|
Z13.0 Encounter for screening for diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism |
|
Z13.1 Encounter for screening for diabetes mellitus |
|
Z13.21 Encounter for screening for nutritional disorder |
|
Z13.220 Encounter for screening for lipoid disorders |
|
Z13.228 Encounter for screening for other metabolic disorders |
|
Z13.29 Encounter for screening for other suspected endocrine disorder |
|
Z13.30 Encounter for screening examination for mental health and behavioral disorders, unspecified |
|
Z13.31 Encounter for screening for depression |
|
Z13.32 Encounter for screening for maternal depression |
|
Z13.39 Encounter for screening examination for other mental health and behavioral disorders |
|
Z13.40 Encounter for screening for unspecified developmental delays |
|
Z13.41 Encounter for autism screening |
|
Z13.42 Encounter for screening for global developmental delays (milestones) |
|
Z13.49 Encounter for screening for other developmental delays |
|
Z13.5 Encounter for screening for eye and ear disorders |
|
Z13.6 Encounter for screening for cardiovascular disorders |
|
Z13.71 Encounter for nonprocreative screening for genetic disease carrier status |
|
Z13.79 Encounter for other screening for genetic and chromosomal anomalies |
|
Z13.810 Encounter for screening for upper gastrointestinal disorder |
|
Z13.811 Encounter for screening for lower gastrointestinal disorder |
|
Z13.818 Encounter for screening for other digestive system disorders |
|
Z13.820 Encounter for screening for osteoporosis |
|
Z13.828 Encounter for screening for other musculoskeletal disorder |
|
Z13.83 Encounter for screening for respiratory disorder NEC |
|
Z13.84 Encounter for screening for dental disorders |
|
Z13.850 Encounter for screening for traumatic brain injury |
|
Z13.858 Encounter for screening for other nervous system disorders |
|
Z13.88 Encounter for screening for disorder due to exposure to contaminants |
|
Z13.89 Encounter for screening for other disorder |
|
Z13.9 Encounter for screening, unspecified |
|
Z14.01 Asymptomatic hemophilia A carrier |
|
Z14.02 Symptomatic hemophilia A carrier |
|
Z14.1 Cystic fibrosis carrier |
|
Z14.8 Genetic carrier of other disease |
|
Z15.01 Genetic susceptibility to malignant neoplasm of breast |
|
Z15.02 Genetic susceptibility to malignant neoplasm of ovary |
|
Z15.03 Genetic susceptibility to malignant neoplasm of prostate |
|
Z15.04 Genetic susceptibility to malignant neoplasm of endometrium |
|
Z15.09 Genetic susceptibility to other malignant neoplasm |
|
Z15.81 Genetic susceptibility to multiple endocrine neoplasia [MEN] |
|
Z15.89 Genetic susceptibility to other disease |
|
Z16.10 Resistance to unspecified beta lactam antibiotics |
|
Z16.11 Resistance to penicillins |
|
Z16.12 Extended spectrum beta lactamase (ESBL) resistance |
|
Z16.19 Resistance to other specified beta lactam antibiotics |
|
Z16.20 Resistance to unspecified antibiotic |
|
Z16.21 Resistance to vancomycin |
|
Z16.22 Resistance to vancomycin related antibiotics |
|
Z16.23 Resistance to quinolones and fluoroquinolones |
|
Z16.24 Resistance to multiple antibiotics |
|
Z16.29 Resistance to other single specified antibiotic |
|
Z16.30 Resistance to unspecified antimicrobial drugs |
|
Z16.31 Resistance to antiparasitic drug(s) |
|
Z16.32 Resistance to antifungal drug(s) |
|
Z16.33 Resistance to antiviral drug(s) |
|
Z16.341 Resistance to single antimycobacterial drug |
|
Z16.342 Resistance to multiple antimycobacterial drugs |
|
Z16.35 Resistance to multiple antimicrobial drugs |
|
Z16.39 Resistance to other specified antimicrobial drug |
|
Z17.0 Estrogen receptor positive status [ER+] |
|
Z17.1 Estrogen receptor negative status [ER-] |
|
Z18.01 Retained depleted uranium fragments |
|
Z18.09 Other retained radioactive fragments |
|
Z18.10 Retained metal fragments, unspecified |
|
Z18.11 Retained magnetic metal fragments |
|
Z18.12 Retained nonmagnetic metal fragments |
|
Z18.2 Retained plastic fragments |
|
Z18.31 Retained animal quills or spines |
|
Z18.32 Retained tooth |
|
Z18.33 Retained wood fragments |
|
Z18.39 Other retained organic fragments |
|
Z18.81 Retained glass fragments |
|
Z18.83 Retained stone or crystalline fragments |
|
Z18.89 Other specified retained foreign body fragments |
|
Z18.9 Retained foreign body fragments, unspecified material |
|
Z19.1 Hormone sensitive malignancy status |
|
Z19.2 Hormone resistant malignancy status |
|
Z20.01 Contact with and (suspected) exposure to intestinal infectious diseases due to Escherichia coli (E. coli) |
|
Z20.09 Contact with and (suspected) exposure to other intestinal infectious diseases |
|
Z20.1 Contact with and (suspected) exposure to tuberculosis |
